Contact

Our portfolio

Primagen

Primagen Holding focuses on developing molecular diagnostic tests and investing in bio- and medtech startups. The company generates revenues through the licensing of their diagnostics technology. Primagen Holding’s portfolio includes investments in PulseCath and Akkolens International.

  • Institute: Amsterdam UMC
Industry: Diagnostics, Infectious Disease
  • Founding year: 1993
Visit website

Want to get in contact about Primagen?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Plantics
Reducing plastic waste and lowering CO2 emissions.
Kling Biotherapeutics
Discovering novel antibodies for cancer and infectious disease treatments.
CRCbioscreen
Developing stool-based colorectal cancer screening for early detection.
Confocal NL
Enhancing microscopes with low-power super-resolution imaging solutions.
Plantics
Reducing plastic waste and lowering CO2 emissions.
Kling Biotherapeutics
Discovering novel antibodies for cancer and infectious disease treatments.
CRCbioscreen
Developing stool-based colorectal cancer screening for early detection.
Confocal NL
Enhancing microscopes with low-power super-resolution imaging solutions.
Explore full AAV portfolio
Contact